Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1986703

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1986703

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies (Computed Tomography, Magnetic Resonance Imaging)), By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neurodiagnostics Market Summary

The global neurodiagnostics market size was estimated at USD 19.01 billion in 2025 and is projected to reach USD 36.57 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, and depression, which are creating sustained demand for accurate and early diagnostic solutions.

In addition, the rising geriatric population is significantly contributing to market expansion, as elderly individuals are more susceptible to neurodegenerative and cerebrovascular diseases.

Technological advancements such as AI-integrated imaging, portable EEG devices, and high-resolution MRI and CT systems are improving diagnostic accuracy and workflow efficiency, further accelerating adoption across hospitals and diagnostic centers.

The advancements in neuroimaging technologies and the launch of new and innovative technologies by the key players in the market are further anticipated to drive market growth. For instance, in January 2025, Siemens Healthineers unveiled its latest diagnostic imaging innovations at the Asian Oceanian Congress of Radiology (AOCR) 2025 held in Chennai, strengthening its commitment to transforming healthcare through safe, accessible, flexible, and sustainable technologies that support improved patient care.

The showcase featured the Dry Cool technology-enabled, virtually helium-free 1.5T MAGNETOM Flow MRI, the Dual Source CT scanner SOMATOM Pro. Pulse, the locally manufactured Digital X-ray system MULTIX Impact E, and AI-powered ultrasound systems ACUSON Maple and ACUSON Sequoia. These solutions are designed to enhance diagnostic accuracy, improve workflow efficiency, and expand access to high-quality imaging, particularly across diverse healthcare settings.

Depression drives growth in the neurodiagnostic industry. The rising global burden of depressive disorders is increasing demand for objective brain-based evaluation tools such as MRI, PET, and EEG to better understand disease mechanisms, support research, and guide treatment selection. Depression is a significant mental health disorder worldwide and a leading cause of disability, creating sustained clinical and research demand for advanced neurological assessment technologies. Neuroimaging and neurophysiological techniques are used to study brain circuit changes, identify biomarkers, and support the development of personalized therapies, which directly expands the use of neurodiagnostic equipment and services.

Global Neurodiagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurodiagnostics market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Neuroimaging Technologies
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Nuclear Medicine Imaging (PET, SPECT)
    • Near infrared spectroscopic imaging (NIRS)
    • Electro-encephalography (EEG)
    • Magneto-encephalography (MEG)
    • Voxel based morphometry (VBM)
  • In Vitro Diagnostics
  • Neuroinformatics
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-277-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising prevalence of neurological disorders
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Government and private sector funding
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of equipment and procedures
      • 3.3.2.2. Limited reimbursement in emerging economies
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Emergence of portable and point-of-care neurodiagnostic devices
      • 3.3.3.2. Rising adoption in emerging markets
    • 3.3.4. Market Challenge Analysis
      • 3.3.4.1. Data privacy and integration issues
  • 3.4. Neurodiagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurodiagnostics Market: Technology Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Neuroimaging Technologies
    • 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Computed Tomography (CT)
      • 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Magnetic Resonance Imaging (MRI)
      • 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
      • 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Near infrared spectroscopic imaging (NIRS)
      • 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Electro-encephalography (EEG)
      • 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Magneto-encephalography (MEG)
      • 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.8. Voxel based morphometry (VBM)
      • 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. In Vitro Diagnostics
    • 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Neuroinformatics
    • 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurodiagnostics Market: End Use Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Hospitals and Clinics
    • 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Imaging Centers
    • 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis, by Technology and by End Use

  • 6.1. Neurodiagnostics Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Share Analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. Canon Medical Systems Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Natus Medical Incorporated (ARCHIMED)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Lifelines Neuro (SIDIS)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Advanced Brain Monitoring, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. GE HealthCare.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Mitsar Co. LTD.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. Deymed Diagnostic
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Neurosoft
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Cadwell Industries
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Compumedics Limited
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
Show more
Product Code: GVR-1-68038-277-8

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 3 North America Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 4 North America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 6 U.S. Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 7 Canada Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 8 Canada Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 9 Mexico Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 10 Mexico Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 11 Europe Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 12 Europe Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 13 Europe Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 14 Germany Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 15 Germany Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 16 UK Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 17 UK Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 18 France Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 19 France Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 20 Italy Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 21 Italy Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 22 Spain Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 23 Spain Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 24 Denmark Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 25 Denmark Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 26 Sweden Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 27 Sweden Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 28 Norway Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 29 Norway Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 30 Asia Pacific Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 31 Asia Pacific Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 32 Asia Pacific Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 33 China Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 34 China Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 35 Japan Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 36 Japan Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 37 India Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 38 India Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 39 South Korea Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 40 South Korea Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 41 Australia Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 42 Australia Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 43 Thailand Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 44 Thailand Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 45 Latin America Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 46 Latin America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 47 Latin America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 48 Brazil Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 49 Brazil Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 50 Argentina Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 51 Argentina Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 52 MEA Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 53 MEA Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 54 MEA Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 55 South Africa Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 56 South Africa Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 57 Saudi Arabia Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 58 Saudi Arabia Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 59 UAE Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 60 UAE Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 61 Kuwait Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 62 Kuwait Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Neurodiagnostics Market: Market Outlook
  • Fig. 9 Neurodiagnostics Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Related/Ancillary Market Outlook
  • Fig. 12 Penetration And Growth Prospect Mapping
  • Fig. 13 Industry Value Chain Analysis
  • Fig. 14 Neurodiagnostics Market Driver Impact
  • Fig. 15 Neurodiagnostics Market Restraint Impact
  • Fig. 16 Neurodiagnostics Market Strategic Initiatives Analysis
  • Fig. 17 Neurodiagnostics Market: Technology Movement Analysis
  • Fig. 18 Neurodiagnostics Market: Technology Outlook And Key Takeaways
  • Fig. 19 Technology Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 20 Neuroimaging Technologies Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 21 Computed Tomography (CT) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 22 Magnetic Resonance Imaging (MRI) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 23 Nuclear Medicine Imaging (PET, SPECT) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 24 Near Infrared Spectroscopic Imaging (NIRS) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 Electro-Encephalography (EEG) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 26 Magneto-Encephalography (MEG) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 27 Voxel Based Morphometry (VBM) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 28 In Vitro Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Neuroinformatics Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Neurodiagnostics Market: End Use Movement Analysis
  • Fig. 31 Neurodiagnostics Market: End Use Outlook And Key Takeaways
  • Fig. 32 Hospitals & Clinics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Diagnostic Laboratories Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 Imaging Centers Market Estimates And Forecasts,2021 - 2033 (USD Billion)
  • Fig. 35 Others Market Estimates And Forecasts,2021 - 2033 (USD Billion)
  • Fig. 36 North America Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 U.S. Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Canada Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 39 Mexico Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 40 Europe Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 UK Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Germany Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 France Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 Italy Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Spain Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 Denmark Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 Sweden Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Norway Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Asia Pacific Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 China Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Japan Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 India Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Thailand Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 South Korea Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 Australia Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Latin America Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 Brazil Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 Argentina Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Middle East And Africa Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 South Africa Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Saudi Arabia Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 UAE Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 Kuwait Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 Market Share of Key Market Players- Neurodiagnostics Market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!